Clinical Trials Browser

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT07277413 2026-04-03

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

GastrointestinalGenitourinaryOther solid neoplasmThoracic

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Mesothelioma, Neoplasm Metastasis, Recurrence

NCT06251310 2026-04-01

SW-682 in Advanced Solid Tumors

Phase 1 Recruiting

186 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT06566079 2026-02-17

Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors

Phase 1 Recruiting

100 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Neoplasm Metastasis

NCT05568680 2026-02-10

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Phase 1 Recruiting

42 enrolled

GynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Ovarian Neoplasms

NCT07192900 2026-01-15

(RIOT 4A)

Phase 1 Recruiting

10 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT03760575 2025-12-04

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Phase 1 Recruiting

20 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05107674 2025-09-09

A Study of NX-1607 in Adults With Advanced Malignancies

Phase 1 Recruiting

345 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Lymphoma, Large B-Cell, Diffuse, Triple Negative Breast Neoplasms

NCT06756035 2025-07-31

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Phase 1 Recruiting

70 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT03917043 2025-06-18

APG-2449 in Patients With Advanced Solid Tumors

Phase 1 Recruiting

165 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms

NCT05304208 2025-04-25

ENSURE

Phase 1 Recruiting

16 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT06726564 2024-12-10

A Study of MT027 in Patients with Pleural Malignant Tumors

Phase 1 Recruiting

18 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Neoplasm Metastasis, Pleural Effusion, Malignant

Clinical Trials

RIOT 4B

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

SW-682 in Advanced Solid Tumors

Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

(RIOT 4A)

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

A Study of NX-1607 in Adults With Advanced Malignancies

CT-95 in Advanced Cancers Associated With Mesothelin Expression

APG-2449 in Patients With Advanced Solid Tumors

ENSURE

A Study of MT027 in Patients with Pleural Malignant Tumors